Skip to Main Content Menu Search Site

CogniXense for Rare Disease Drug Discovery

High-throughput, whole-organism drug discovery platform for rare genetic diseases


Bioinspired Therapeutics and Diagnostics

Key Features
  • High-throughput platform can analyze up to 1,000 live tadpole models simultaneously and non-invasively, providing whole-organism cognitive, behavioral, and physiological data
  • Platform is target-agnostic, allowing it to be used to identify existing and novel drugs for many rare genetic diseases
  • System uses real patient data to ensure that drugs actually alleviate symptoms in patients suffering from disease
Close menu